Argyris Michalopoulos

Author

Also Known As

A Michalopoulos, A. Michalopoulos, A. S. Michalopoulos, A.S. Michalopoulos, Argyris Michalopoulos, Argyris S Michalopoulos, Argyris S. Michalopoulos

366

Publications

8.2K

Citations

H-Index

Concepts

All Affiliations

Henry Dunant Hospital Alfa Institute of Biomedical Sciences Tufts University Onassis Cardiac Surgery Center University of Crete

About

Argyris Michalopoulos is an author at Henry Dunant Hospital specializing in medicine, infection control, and antibiotics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	31	3.1K
2	Health Sciences	13	14	1.4K
3	Public Health	2	2	206
4	Education	1	1	10
5	Social Sciences	1	1	69

Argyris Michalopoulos

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
High Tidal Volume and Positive Fluid Balance Are Associated With Worse Outcome in Acute Lung Injury Yasser Sakr, Jean‐Louis Vincent, Konrad Reinhart, CHEST Journal Acute Lung InjuryWorse OutcomePulmonary CirculationAcute CarePulmonary Physiology	2005	402
Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients Matthew E. Falagas, Petros I. Rafailidis, Elda Ioannidou, International Journal of Antimicrobial Agents Retrospective Cohort StudyAntimicrobial SusceptibilityHealth SciencesAntibioticsColistin Therapy	2009	297
Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic Argyris Michalopoulos, Sotirios Tsiodras, Kostas Rellos, Clinical Microbiology and Infection Multiresistant Gram-negative BacteriaAntimicrobial SusceptibilityAntibioticsColistin TreatmentHealthcare-associated Infection	2005	288
Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study Matthew E. Falagas, Petros I. Rafailidis, Diamantis P. Kofteridis, Journal of Antimicrobial Chemotherapy	2007	249
Toxicity after prolonged (more than four weeks) administration of intravenous colistin Matthew E. Falagas, Michael Rizos, Ioannis A. Bliziotis, BMC Infectious Diseases	2005	242
Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria Matthew E. Falagas, Ioannis A. Bliziotis, Sofia K. Kasiakou, BMC Infectious Diseases	2005	220
Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis Argyris Michalopoulos, Sofia K. Kasiakou, Zefi Mastora, Critical Care	2004	206
Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: A prospective study Argyris Michalopoulos, Dimitris Fotakis, Simona Virtzili, Respiratory Medicine Aerosolized ColistinHealth SciencesAntimicrobial SusceptibilityRespiratory InfectionInfectious Respiratory Disease	2008	188
Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation Argyris Michalopoulos, Simona Virtzili, Petros I. Rafailidis, Clinical Microbiology and Infection Antimicrobial SusceptibilityHealth SciencesAntibioticsIntravenous FosfomycinCarbapenem-resistant Klebsiella Pneumoniae	2009	187
Combination Therapy with Intravenous Colistin for Management of Infections Due to Multidrug-Resistant Gram-Negative Bacteria in Patients without Cystic Fibrosis Sofia K. Kasiakou, Argyris Michalopoulos, Elpidoforos S. Soteriades, Antimicrobial Agents and Chemotherapy	2005	183

Page 1